October 3, 2025
1 min read

FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing

The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry stakeholders this week to take comments on a proposed program to streamline the buildouts of new U.S. manufacturing plants.

Leave a Reply

Your email address will not be published.

Previous Story

Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate

Next Story

Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India

Previous Story

Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate

Next Story

Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop